Welcome to Lamellar Biomedical
Lamellar is developing a range of patent protected medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies. Diseases which may benefit from the application of Lamellasome™ mimetics of the body’s lamellar bodies include Dry Mouth, Dry Eye and Cystic Fibrosis.
Learn moreResearch & Development
Lamellar in partnership with clinical centres-of-excellence is highly advanced in developing novel products for Dry Mouth, Dry Eye and Cystic Fibrosis.
Learn moreInvestors
Lamellar Biomedical Shareholders comprise both institutional and private investors.
Learn more
Lamellar Biomedical
An innovative, biotechnology company bringing new patent protected medical devices and pharmaceutical products to the healthcare market.
Strategic Goals
To successfully develop and commercialise multiple medical devices and pharmaceuticals based on Lamellar’s proprietary Lamellasome™ technology.
Product pipeline
Lamellar's patented Lamellasome™ technology has the ability play an important role in treating a broad range of poorly served medical conditions.